+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Dermatologicals in Romania

  • PDF Icon

    Report

  • 21 Pages
  • September 2023
  • Region: Romania
  • Euromonitor International
  • ID: 2651914
International players with broad portfolios continue to lead the way in dermatologicals, with Bayer Romania the top-ranked company. Bayer Romania’s Canesten, the best-selling product in both topical and vaginal antifungals, is expected to maintain brand leadership in dermatologicals. In addition, Bayer Romania’s Bepanthen is set to remain the leader in antipruritics and nappy (diaper) rash treatments.

The analyst's Dermatologicals in Romania report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.

Product coverage:
Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage:
Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

  • Get a detailed picture of the Dermatologicals market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.

Table of Contents

DERMATOLOGICALS IN ROMANIAKEY DATA FINDINGS
2023 DEVELOPMENTS
  • Bayer retains lead with Canesten and Bepanthen
  • Broad availability supports demand
  • Urban pollution and stressful lifestyles boost demand
PROSPECTS AND OPPORTUNITIES
  • Rising demand for haemorrhoid treatments
  • Further growth of e-commerce expected
  • Manufacturers set to invest in consumer education
CATEGORY DATA
  • Table 1 Sales of Dermatologicals by Category: Value 2018-2023
  • Table 2 Sales of Dermatologicals by Category: % Value Growth 2018-2023
  • Table 3 NBO Company Shares of Dermatologicals: % Value 2019-2023
  • Table 4 LBN Brand Shares of Dermatologicals: % Value 2020-2023
  • Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2020-2023
  • Table 6 Forecast Sales of Dermatologicals by Category: Value 2023-2028
  • Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2023-2028
CONSUMER HEALTH IN ROMANIA
EXECUTIVE SUMMARY
  • Consumer health in 2023: The big picture
  • 2023 key trends
  • Competitive landscape
  • Retailing developments
  • What next for consumer health?
MARKET INDICATORS
  • Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2018-2023
  • Table 9 Life Expectancy at Birth 2018-2023
MARKET DATA
  • Table 10 Sales of Consumer Health by Category: Value 2018-2023
  • Table 11 Sales of Consumer Health by Category: % Value Growth 2018-2023
  • Table 12 NBO Company Shares of Consumer Health: % Value 2019-2023
  • Table 13 LBN Brand Shares of Consumer Health: % Value 2020-2023
  • Table 14 Distribution of Consumer Health by Format: % Value 2018-2023
  • Table 15 Distribution of Consumer Health by Format and Category: % Value 2023
  • Table 16 Forecast Sales of Consumer Health by Category: Value 2023-2028
  • Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2023-2028
APPENDIX
  • OTC registration and classification
  • Vitamins and dietary supplements registration and classification
  • Self-medication/self-care and preventive medicine
  • Switches
DISCLAIMERDEFINITIONS
SOURCES
  • Summary 1 Research Sources